NGS	Next-generation sequencing
TT	Targeted therapy
CT	Chemotherapy
NB	Neuroblastoma
FISH	Fluorescence In Situ Hybridization
MLPA	Multiplex Ligation-dependent Probe Amplification
CTCAE	Common Terminology Criteria for Adverse Events
RMS	Rhabdomyosarcoma
STS	Soft-tissue sarcoma
GIST	Gastrointestinal stromal tumor
MRT	Malignant rhabdoid tumor
CR	Complete response
VGPR	Very good partial response
PR	Partial response
HR	High-risk group
IR	Intermediate-risk group
LR	Low-risk group
MNA	MYCN amplification